AU4765197A – Genetic mechanisms of tumor suppression
– Google Patents
AU4765197A – Genetic mechanisms of tumor suppression
– Google Patents
Genetic mechanisms of tumor suppression
Info
Publication number
AU4765197A
AU4765197A
AU47651/97A
AU4765197A
AU4765197A
AU 4765197 A
AU4765197 A
AU 4765197A
AU 47651/97 A
AU47651/97 A
AU 47651/97A
AU 4765197 A
AU4765197 A
AU 4765197A
AU 4765197 A
AU4765197 A
AU 4765197A
Authority
AU
Australia
Prior art keywords
tumor suppression
genetic mechanisms
suppression
genetic
mechanisms
Prior art date
1990-08-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47651/97A
Inventor
Phang-Lang Chen
Wen-Hwa Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1990-08-24
Filing date
1997-12-09
Publication date
1998-03-26
Family has litigation
First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=24291866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4765197(A)
“Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
1997-12-09
Application filed by University of California
filed
Critical
University of California
1998-03-26
Publication of AU4765197A
publication
Critical
patent/AU4765197A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
A method for utilizing p53 cDNA, and p53 gene products for the suppression of the neoplastic phenotype.
AU47651/97A
1990-08-24
1997-12-09
Genetic mechanisms of tumor suppression
Abandoned
AU4765197A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US57340590A
1990-08-24
1990-08-24
US573405
1990-08-24
Related Parent Applications (1)
Application Number
Title
Priority Date
Filing Date
AU82629/91A
Division
AU653356B2
(en)
1990-08-24
1991-08-20
Genetic mechanisms of tumor suppression
Related Child Applications (1)
Application Number
Title
Priority Date
Filing Date
AU56593/00A
Division
AU5659300A
(en)
1990-08-24
2000-09-08
Genetic mechanisms of tumour suppression
Publications (1)
Publication Number
Publication Date
AU4765197A
true
AU4765197A
(en)
1998-03-26
Family
ID=24291866
Family Applications (3)
Application Number
Title
Priority Date
Filing Date
AU82629/91A
Ceased
AU653356B2
(en)
1990-08-24
1991-08-20
Genetic mechanisms of tumor suppression
AU81836/94A
Abandoned
AU8183694A
(en)
1990-08-24
1994-12-29
Genetic mechanisms of tumor suppression
AU47651/97A
Abandoned
AU4765197A
(en)
1990-08-24
1997-12-09
Genetic mechanisms of tumor suppression
Family Applications Before (2)
Application Number
Title
Priority Date
Filing Date
AU82629/91A
Ceased
AU653356B2
(en)
1990-08-24
1991-08-20
Genetic mechanisms of tumor suppression
AU81836/94A
Abandoned
AU8183694A
(en)
1990-08-24
1994-12-29
Genetic mechanisms of tumor suppression
Country Status (11)
Country
Link
EP
(2)
EP0475623B1
(en)
JP
(1)
JP2838090B2
(en)
KR
(1)
KR970000189B1
(en)
AT
(1)
ATE136793T1
(en)
AU
(3)
AU653356B2
(en)
CA
(1)
CA2047090C
(en)
DE
(1)
DE69118789T2
(en)
DK
(1)
DK0475623T3
(en)
ES
(1)
ES2085966T3
(en)
FI
(1)
FI105014B
(en)
NO
(1)
NO312681B1
(en)
Families Citing this family (34)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
IE911115A1
(en)
*
1990-04-10
1991-10-23
Canji Inc
Gene therapy for cell proliferative diseases
WO1992015680A1
(en)
1991-03-06
1992-09-17
Board Of Regents, The University Of Texas System
Methods and compositions for the selective inhibition of gene expression
US5747469A
(en)
*
1991-03-06
1998-05-05
Board Of Regents, The University Of Texas System
Methods and compositions comprising DNA damaging agents and p53
US6410010B1
(en)
1992-10-13
2002-06-25
Board Of Regents, The University Of Texas System
Recombinant P53 adenovirus compositions
WO1993024525A1
(en)
*
1992-05-26
1993-12-09
Rijksuniversiteit Leiden
PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
WO1994006910A1
(en)
*
1992-09-18
1994-03-31
Canji, Inc.
Gene therapy by retroviral vector with tumor suppressive gene
GB9224784D0
(en)
*
1992-11-26
1993-01-13
Univ Dundee
Cellular protein
CA2086577A1
(en)
*
1992-12-31
1994-07-01
Rick E. Preddie
Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene
IL107250A
(en)
*
1993-10-12
2001-08-08
Yeda Res & Dev
Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins
US6160106A
(en)
*
1993-10-12
2000-12-12
Yeda Research & Development Co., Ltd.
Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
WO1995011301A1
(en)
*
1993-10-19
1995-04-27
The Regents Of The University Of Michigan
P53-mediated apoptosis
FR2712602B1
(en)
*
1993-11-18
1996-02-09
Centre Nat Rech Scient
Recombinant viruses, preparation and use in gene therapy.
US5700657A
(en)
*
1993-12-13
1997-12-23
Genzyme Corporation
Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby
US5573925A
(en)
*
1994-11-28
1996-11-12
The Wistar Institute Of Anatomy And Biology
P53 proteins with altered tetramerization domains
US5721340A
(en)
*
1994-11-28
1998-02-24
The Wistar Institute Of Anatomy & Biology
p53 proteins with altered tetramerization domains
AU705563B2
(en)
1995-07-28
1999-05-27
Marie Curie Cancer Care
Transport proteins and their uses
GB9519275D0
(en)
1995-09-21
1995-11-22
Univ Dundee
Substances and their therapeutic use
GB9519299D0
(en)
1995-09-21
1995-11-22
Farrar Gwyneth J
Genetic strategy
US5847083A
(en)
*
1996-08-21
1998-12-08
The Wistar Institute Of Anatomy And Biology
Modified p53 constructs which enhance DNA binding
US6656480B2
(en)
1996-01-11
2003-12-02
Corixa Corporation
Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2
(en)
1996-01-11
2007-07-10
Corixa Corporation
Compositions and methods for the therapy and diagnosis of breast cancer
US6861506B1
(en)
1996-01-11
2005-03-01
Corixa Corporation
Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1
(en)
1999-04-09
2004-12-07
Corixa Corporation
Compositions and methods for the therapy and diagnosis of breast cancer
GB9606961D0
(en)
1996-04-02
1996-06-05
Farrar Gwyneth J
Genetic strategy III
US8551970B2
(en)
1996-04-02
2013-10-08
Optigen Patents Limited
Genetic suppression and replacement
US5876972A
(en)
*
1996-09-23
1999-03-02
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
US7732129B1
(en)
1998-12-01
2010-06-08
Crucell Holland B.V.
Method for the production and purification of adenoviral vectors
ES2383640T3
(en)
1996-11-20
2012-06-25
Crucell Holland B.V.
Adenovirus compositions that can be obtained by an improved production and purification method
US6017735A
(en)
*
1997-01-23
2000-01-25
Marie Curie Cancer Care
Materials and methods for intracellular transport and their uses
CA2214461A1
(en)
1997-09-02
1999-03-02
Mcgill University
Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53
AU3208699A
(en)
1998-03-27
1999-10-18
Johns Hopkins University, The
P40 protein acts as an oncogene
US6689600B1
(en)
1998-11-16
2004-02-10
Introgen Therapeutics, Inc.
Formulation of adenovirus for gene therapy
CA2576159A1
(en)
2004-08-27
2006-03-02
Cyclacel Limited
Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
EP1815029A4
(en)
2004-11-03
2009-06-10
Introgen Therapeutics Inc
A novel method for the production and purification of adenoviral vectors
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5362623A
(en)
*
1991-06-14
1994-11-08
The John Hopkins University
Sequence specific DNA binding by p53
IE911115A1
(en)
*
1990-04-10
1991-10-23
Canji Inc
Gene therapy for cell proliferative diseases
ATE325813T1
(en)
*
1990-06-27
2006-06-15
Univ Princeton
PROTEIN COMPLEX P53/P90
1991
1991-07-08
NO
NO19912665A
patent/NO312681B1/en
not_active
IP Right Cessation
1991-07-15
CA
CA002047090A
patent/CA2047090C/en
not_active
Expired – Fee Related
1991-08-20
AU
AU82629/91A
patent/AU653356B2/en
not_active
Ceased
1991-08-20
JP
JP3232371A
patent/JP2838090B2/en
not_active
Expired – Fee Related
1991-08-22
KR
KR91014477A
patent/KR970000189B1/en
not_active
IP Right Cessation
1991-08-23
DK
DK91307791.3T
patent/DK0475623T3/en
active
1991-08-23
EP
EP91307791A
patent/EP0475623B1/en
not_active
Revoked
1991-08-23
AT
AT91307791T
patent/ATE136793T1/en
not_active
IP Right Cessation
1991-08-23
DE
DE69118789T
patent/DE69118789T2/en
not_active
Revoked
1991-08-23
ES
ES91307791T
patent/ES2085966T3/en
not_active
Expired – Lifetime
1991-08-23
FI
FI913978A
patent/FI105014B/en
not_active
IP Right Cessation
1991-08-23
EP
EP95114723A
patent/EP0710722A1/en
not_active
Withdrawn
1994
1994-12-29
AU
AU81836/94A
patent/AU8183694A/en
not_active
Abandoned
1997
1997-12-09
AU
AU47651/97A
patent/AU4765197A/en
not_active
Abandoned
Also Published As
Publication number
Publication date
EP0710722A1
(en)
1996-05-08
DE69118789D1
(en)
1996-05-23
AU653356B2
(en)
1994-09-29
FI105014B
(en)
2000-05-31
FI913978A
(en)
1992-02-25
EP0475623A1
(en)
1992-03-18
KR970000189B1
(en)
1997-01-06
JPH0759579A
(en)
1995-03-07
NO912665D0
(en)
1991-07-08
AU8183694A
(en)
1995-02-23
DE69118789T2
(en)
1996-09-26
ATE136793T1
(en)
1996-05-15
ES2085966T3
(en)
1996-06-16
NO912665L
(en)
1992-02-25
JP2838090B2
(en)
1998-12-16
EP0475623B1
(en)
1996-04-17
DK0475623T3
(en)
1996-05-13
AU8262991A
(en)
1992-02-27
CA2047090A1
(en)
1992-02-25
CA2047090C
(en)
1998-08-04
NO312681B1
(en)
2002-06-17
FI913978A0
(en)
1991-08-23
Similar Documents
Publication
Publication Date
Title
AU4765197A
(en)
1998-03-26
Genetic mechanisms of tumor suppression
AU7019494A
(en)
1994-12-20
Genetic therapy for cardiovascular disease
GB2239850B
(en)
1993-08-11
Bodyside panel handling conveyor.
EP0570922A3
(en)
1995-06-21
Reproducing apparatus.
AU2606892A
(en)
1993-04-01
.uturing apparatus
AU4392293A
(en)
1993-12-30
Improved cd transport apparatus
AU7056491A
(en)
1991-08-05
Apparatus for reproduction apparatus
AU3700493A
(en)
1993-11-04
Multizone unscrambler
AU659983B2
(en)
1995-06-01
Model-based thermobalance with feedback
AU1567692A
(en)
1992-10-21
Process for preparing an alkanone and/or alkanol
AU4621693A
(en)
1993-11-25
Material handling apparatus
EP0588351A3
(en)
1995-08-02
Hard wear-resistant film and method for production thereof.
AU641748B2
(en)
1993-09-30
Electro-magnetic desensitizer
AU8202091A
(en)
1992-02-04
Transportation apparatus
AU4017693A
(en)
1993-12-16
Laser resistant endotracheal tube, tape and material
EP0619576A3
(en)
1995-04-05
Optical recording medium and process for manufacturing it.
EP0628963A3
(en)
1995-04-12
Disc reproduction apparatus.
EP0581741A3
(en)
1994-11-09
Dietary fibre from barley spent grain and process for preparing the same.
AU4386393A
(en)
1993-12-13
Process for gene targeting and genome manipulations
AUPN571495A0
(en)
1995-10-26
Apparatus for the handling rods
AU6333194A
(en)
1994-12-01
Drug for neuroprotection
AU6243696A
(en)
1997-02-05
Gene preparations
EP0642337A1
(en)
1995-03-15
Dapsone and promin for the treatment of dementia.
EP0566146A3
(en)
1995-07-12
Optical disk apparatus.
EP0573163A3
(en)
1995-08-23
Enhanced durability optical stack such as a mirror and a process for forming the stack.
Legal Events
Date
Code
Title
Description
2000-11-02
MK5
Application lapsed section 142(2)(e) – patent request and compl. specification not accepted
